Insiders NRx Pharmaceuticals, Inc.

Equities

BRPA

US6294442099

Market Closed - Nasdaq Other stock markets 21:00:00 10/05/2024 BST			5-day change	1st Jan Change
3.04 ^USD	+3.75%		+44.76%	-33.91%

05-06	NRx Pharmaceuticals Shares Rise 38% After Positive Drug Trial Data	DJ
05-06	NRx Pharmaceuticals, Inc. Announces Final Clinical Trial Results	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nrx Pharmaceuticals Announces Election of Janet Rehnquist to Its Board of Directors	12-27	CI
NRX Pharmaceuticals, Inc. Appoints Richard Narido, as Principal Financial Officer and Principal Accounting Officer	14/09/23	CI
NRx Pharmaceuticals, Inc. Announces Resignation of Mr. Robert Besthof as Head of Operations and Chief Commercial Officer	23/02/23	CI
Insider Sell: Nrx Pharmaceuticals	09/12/22	MT
Insider Buy: Nrx Pharmaceuticals	21/11/22	MT
Insider Sell: NRX Pharmaceuticals	02/08/22	MT
NRx Pharmaceuticals, Inc. Announces That Alessandra Daigneault Resigned as Chief Corporate Officer, General Counsel and Corporate Secretary	28/07/22	CI
NRX Pharmaceuticals Names Stephen Willard CEO	13/07/22	MT
NRx Pharmaceuticals, Inc. Announces the Appointment of Stephen Willard as its Chief Executive Officer	13/07/22	CI
NRx Pharmaceuticals Announces the Appointment of Stephen Willard as Member of the Company's Board of Directors	13/07/22	CI
Nrx Pharmaceuticals, Inc. Announces Director Resignation	21/06/22	CI
NRx Pharmaceuticals Appoints Seth Van Voorhees Finance Chief	08/06/22	MT
NRx Pharmaceuticals Appoints Seth Van Voorhees as Chief Financial Officer, Effective June 13, 2022	08/06/22	CI
Insider Buy: Nrx Pharmaceuticals	02/06/22	MT
NRx Pharmaceuticals, Inc. Announces the Resignation of Ira Strassberg as Chief Financial Officer, Effective July 18, 2022	25/05/22	CI
NRx Pharmaceuticals, Inc. Announces Executive Changes	25/05/22	CI
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Treasurer	18/03/22	CI
NRX Pharmaceuticals Appoints Ira Strassberg as CFO	18/03/22	MT
NRx Pharmaceuticals, Inc. Appoints Ira Strassberg as Chief Financial Officer and Treasurer	18/03/22	CI
NRx Pharmaceuticals CEO Jonathan Javitt Retires; Interim CEO Named	09/03/22	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders NRx Pharmaceuticals, Inc.

Equities

BRPA

US6294442099

Insiders

Filters